Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with L-leucine
- PMID: 18584311
- DOI: 10.1007/s11095-008-9613-4
Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with L-leucine
Abstract
Purpose: The crystallization and structural integrity of micron-sized inhalable salbutamol sulphate particles coated with L-leucine by different methods are investigated at different humidities. The influence of the L-leucine coating on the crystallization of salbutamol sulphate beneath the coating layer is explored.
Methods: The coated particles are prepared by an aerosol flow reactor method, the formation of the L-leucine coating being controlled by the saturation conditions of the L-leucine. The coating is formed by solute diffusion within a droplet and/or by vapour deposition of L-leucine. The powders are humidified at 0%, 44%, 65% and 75% of relative humidity and the changes in physical properties of the powders are investigated with dynamic vapour sorption analysis (DVS), a differential scanning calorimeter (DSC), and a scanning electron microscope (SEM).
Results: Visual observation show that all the coated particles preserve their structural integrity whereas uncoated salbutamol sulphate particles are unstable at 65% of relative humidity. The coating layer formed by diffusion performs best in terms of its physical stability against moisture and moisture-induced crystallization. The degree of crystallization of salbutamol in the as-prepared powders is within the range 24-35%. The maximum degree of crystallization after drying ranges from 55 to 73% when the salbutamol crystallizes with the aid of moisture. In addition to providing protection against moisture, the L-leucine coating also stabilizes the particle structure against heat at temperatures up to 250 degrees C.
Conclusion: In order to preserve good flowability together with good physical stability, the best coating would contain two L-leucine layers, the inner layer being formed by diffusion (physical stability) and the outer layer by vapour deposition (flowability).
Similar articles
-
Structure and dissolution of L-leucine-coated salbutamol sulphate aerosol particles.AAPS PharmSciTech. 2012 Jun;13(2):707-12. doi: 10.1208/s12249-012-9789-0. Epub 2012 May 5. AAPS PharmSciTech. 2012. PMID: 22562614 Free PMC article.
-
A novel gas phase method for the combined synthesis and coating of pharmaceutical particles.Pharm Res. 2008 Jan;25(1):242-5. doi: 10.1007/s11095-007-9464-4. Epub 2007 Oct 20. Pharm Res. 2008. PMID: 17952569
-
Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders.Int J Pharm. 2009 Jan 5;365(1-2):18-25. doi: 10.1016/j.ijpharm.2008.08.017. Epub 2008 Aug 22. Int J Pharm. 2009. PMID: 18789380
-
Preformulation considerations for controlled release dosage forms. Part I. Selecting candidates.AAPS PharmSciTech. 2008;9(2):635-8. doi: 10.1208/s12249-008-9068-2. Epub 2008 Mar 28. AAPS PharmSciTech. 2008. PMID: 18431655 Free PMC article. Review.
-
Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing.Pharm Res. 2011 Oct;28(10):2386-92. doi: 10.1007/s11095-011-0450-5. Epub 2011 May 5. Pharm Res. 2011. PMID: 21544688 Review.
Cited by
-
In vitro Evaluation of Paliperidone Palmitate Loaded Cubosomes Effective for Nasal-to-Brain Delivery.Int J Nanomedicine. 2023 Mar 1;18:1085-1106. doi: 10.2147/IJN.S397650. eCollection 2023. Int J Nanomedicine. 2023. PMID: 36883068 Free PMC article.
-
Structure and dissolution of L-leucine-coated salbutamol sulphate aerosol particles.AAPS PharmSciTech. 2012 Jun;13(2):707-12. doi: 10.1208/s12249-012-9789-0. Epub 2012 May 5. AAPS PharmSciTech. 2012. PMID: 22562614 Free PMC article.
-
Intact nanoparticulate indomethacin in fast-dissolving carrier particles by combined wet milling and aerosol flow reactor methods.Pharm Res. 2011 Oct;28(10):2403-11. doi: 10.1007/s11095-011-0456-z. Epub 2011 May 4. Pharm Res. 2011. PMID: 21537875
-
Particle surface coating for dry powder inhaler formulations.Expert Opin Drug Deliv. 2025 May;22(5):711-727. doi: 10.1080/17425247.2025.2482052. Epub 2025 Mar 26. Expert Opin Drug Deliv. 2025. PMID: 40101203 Review.
-
Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols.Eur J Pharm Sci. 2011 Nov 20;44(4):522-33. doi: 10.1016/j.ejps.2011.09.014. Epub 2011 Sep 21. Eur J Pharm Sci. 2011. PMID: 21964203 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources